Stephen trained as an infectious diseases physician, immunologist and HIV vaccine scientist in Melbourne and the USA.
Research Interests:
Professor Kent is currently actively investigating within the following Signature Project:
| Publication | Year | Authors |
|---|---|---|
| Antibody-dependent cellular cytotoxicity and influenza virus | 2017 | Vanderven, H.A., Jegaskanda, S., Wheatley, A.K., Kent, S.J. |
| Immunological principles guiding the rational design of particles for vaccine delivery | 2017 | Gause, K.T., Wheatley, A.K., Cui, J., Yan, Y., Kent, S.J., Caruso, F. |
| Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma | 2017 | Selva, K.J,, Kent, S.J., Parsons, M.S. |
| Antibody responses with Fc-mediated functions after vaccination of HIV-infected subjects with trivalent influenza vaccine | 2016 | Kristensen, A.B.; Lay, W.N.; Ana-Sosa-Batiz, F.; Vanderven, H.A.; Madhavi, V.; Laurie, K.L.; Carolan, L.; Wines, B.D.; Hogarth, M.; Wheatley, A.K.; Kent, S.J. |
| Antibody-dependent cellular cytotoxicity against reactivated HIV-1-Infected Cells | 2016 | Lee, W.S.; Richard, J.; Lichtfuss, M.; Smith, A.B.; Park, J.; Courter, J.R.; Melillo, B.N.; Sodroski, J.G.; Kaufmann, D.E.; Finzi, A.; Parsons, M.S.; Kent S.J. |
